Tag: TROV

Blue Horseshoe Stocks: ANY Review & More

Sphere 3D Corp. ANY

We’ve often said in the past that it’s better to be early to the party than late, and ANY is a perfect example of why. We tagged this play on Wednesday after noticing some unusual activity the previous day, and things didn’t really kick off right away. We observed a low of .15 during that session.

Yesterday is when things really moved into high gear, with the stock having an excellent day, trading in a range from .1941 on up to .29 for a 49% rip, and we’ll definitely want to keep tracking the activity into today, as the premarket high has equaled yesterday’s daily high.

From the low of .15 that we saw on Wednesday, ANY’s total upswing thus far has amounted to 93% Quite a respectable two-day jump.

_____

Vivint Solar VSLR Recap – Speaking of solid movers, we also wanted to quickly update the total observed range we’ve seen on VSLR, which reached a new high of 5.50 yesterday. From our witnessed low of 2.75 following our report on the morning of May 18th, that comes out to a nice, round 100%

AVEO Pharmaceuticals, Inc. AVEO

We want to radar AVEO in the wake of the announcement that its advanced renal cell carcinoma treatment has been recommended for EU approval by a scientific committee of the European Medicines Agency. The stock has gapped up into Blue Skies this morning as a result, with a new 52-week high of 1.28.

Concerning the chart itself, the 50DMA is rising toward the 200DMA and it appears as if a Golden Cross is imminent.  We’ll want to see AVEO hold at or above recent resistance at .89 on any dips in order to hold our interest.

Bed Bath and Beyond, Inc. BBBY – Options Idea

We’re bearish on BBBY following the company’s post-market earning miss yesterday, which has caused a breach of trend-line support to the low side. We’ll be observing the BBBY Weekly $31.50-30.50 Puts* for possible day trade opportunities.

*We don’t include mentions of weekly options contracts on a Friday without explicitly warning our readers every time. Trading weekly options at the end of the week is a hugely risky proposition that should never be attempted unless you are an expert trader! 

Extended Watchlist:
DTII, IDRA, TROV, AKS, FALC, BDSI, MARA

Blue Horseshoe Stocks: TROV Recap & More

TrovaGene, Inc. TROV

We wanted to swing back around this morning for a stock that we mentioned on Monday of last week. We said we’d want to have it on watch in later sessions, as the company had just released news of a service agreement with pharma giant AstraZeneca.

There was a slight pullback off of the initial spike that the announcement caused that day, and TROV found support at a low of .85. This morning the stock has reached as high as 1.35 in the premarket, which marks a rise of 59% over the lows we observed last week.

We want to continue to keep an eye on TROV and see it make higher highs and higher lows. If the stock can hold at or above previous resistance at 1.20 on any pullbacks, it’ll be a positive signal.


Marathon Patent Group, Inc. MARA

Hitting our radars as a bottom-bouncer this morning is MARA, which popped up yesterday with its first significantly bullish session in quite some time. It had been pretty well oversold for months, as you can see on the accompanying chart snapshot.

We’ll be interested to see if MARA can put together a multi-day trend, or if yesterday’s move was an aberration. The first step will be a breach of the current 50DMA at .40, which also coincides with an an area of considerable previous resistance.


_____

Highway Holdings Ltd. HIHO – Another potential bottom play we wanted to quickly point out this morning is HIHO. We’ve noticed that the stock has come up off of a double-bottom formation and has been holding support well at the 3.30 level over the past few sessions. We’ll look for it to continue to do so.

The

Extended Watchlist:
OVAS, CTRV, ORCL, AAL, CMC, BKS

Blue Horseshoe Stocks: DCTH Review & More

Delcath Systems, Inc. DCTH
We flagged DCTH in Friday’s premarket reportas a prime bottom-bounce candidate that could be in line for a serious rebound, and even despite the markets as a whole taking a gut punch, it ended up being a great single-session play, and the NASDAQ’s top gainer.

From an early low of .0501 the stock surged as high as .0845, which works out to an intraday rise of 69% and it occurred on more than ten times the 30-day average volume, with DCTH logging its second-highest daily volume of all time.

We’d say our timing was extremely fortuitous on this rebound play, and with the kind price action and liquidity that we witnessed Friday, we’ll definitely be interested to see how the action unfolds to kick off this new trading week.

TrovaGene, Inc. TROV

We wanted to make mention of TROV this morning after noticing a cherry of a PR buzzing over the newswires. The company announced an agreement to provide tests and services for pharma giant AstraZeneca.

Whenever we see one of these smaller pharma company’s have joint news with a big player in the sector, we always want to pay attention to the stock. A perfect example of this is Pieris Pharmaceuticals, Inc. PIRS, which we signaled back on May 4th when that company also had news tying it to none other than AstraZeneca. What followed was a 55% run lasting nearly a month that took it from 3.26 the following day to a high of 5.06 last Monday, the 31st.

On the chance that TROV experiences a similar bullish push on the heels of its own AstraZeneca announcement, we’re going to be sure to have this one on watch in coming sessions.

Ascena Retail Group, Inc. ASNA

We’re also taking notice of a nice technical setup on ASNA, which owns the Lane Bryant retail brand among others, and was another of the NASDAQ’s top gainers of the day on Friday.

The activity came in the wake of a rather disappointing earnings release in terms of financials, but investors clearly responded well to the company outlook moving forward.

As you can see on the included snapshot, the stock picked up speed in its recent ascent off of a bottom, and began to fill a gap on the chart to the upside. We also have a number of other indicators pointing to a possible continued uptrend, so we’ll afford this stock a slot on our watchlist.

Extended Watchlist:
XBIT, DXTR, RWLK, ABIL, ADHD, ENRJ